Novo Nordisk Slashes Wegovy Prices in China by 50%
Novo Nordisk cuts Wegovy obesity drug prices by half in Chinese provinces as patent expiration looms and local competitors prepare cheaper alternatives.
/ 10 items
#JD↓
PDD Holdings Beats Earnings But Warns of Tough Times Ahead
PDD Holdings (PDD) reports 9% revenue growth and beats profit forecasts, but shares fall as company cautions about fierce competition and regulatory challenges affecting its China and Temu businesses.
China’s Singles’ Day Sales Soar with AI Boost
Alibaba, JD.com, and Douyin see record-breaking Singles’ Day sales as AI helps brands grow amid a slow economy.
JD.com Beats Q3 Revenue Forecasts Despite Profit Plunge on New Business Investments
JD.com's (JD) Q3 revenue surged 15% to $42B, surpassing estimates with Singles Day success and 700M active users, though net income dropped 55% amid aggressive expansion into food delivery.